KENNEDY ELDRIDGE: Open Payments
NPI 1750061875 · JOHNSON CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$890 in 47 payments from 10 companies in 2025. Trend: 2023 $561 · 2024 $1,542 · 2025 $890
Food & beverage: $890
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $269 |
| Neurocrine BioSciences, Inc. | 6 | $133 |
| Teva Pharmaceuticals USA, Inc. | 4 | $122 |
| Alkermes, Inc. | 6 | $115 |
| Janssen Pharmaceuticals, Inc | 4 | $82 |
| Vanda Pharmaceuticals Inc. | 3 | $65 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
| ABBVIE INC. | 2 | $33 |
| Lundbeck LLC | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: INGREZZA, UZEDY, ABILIFY MAINTENA, ARISTADA, REXULTI, INVEGA SUSTENNA, HETLIOZ, ABILIFY ASIMTUFII.
Industry payments across TN — which companies pay providers there.
